Surzen Biotherapeutics founders/team

Six people stood outside a building and a sign saying ‘OIST Innovation Core 2’.

The team behind Surzen Biotherapeutics’ launch, stood by their new lab space at OIST. Pictured from left to right are Angela Ares Pita (OIST Innovation), Yusuke Wada (Saisei Ventures), James Feliciano (Saisei Ventures and CEO of Surzen Biotherapeutics, Paola Butler-Zanetti (OIST Innovation), Peng Zhou, (Chief Technology Officer, Surzen Biotherapeutics) and Shuhei Tomimoto (Senior Director of Operations, Surzen Biotherapeutics).

Date:
07 April 2026
Credit:
Kanayo Noda
Share on: